These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Oliveira ML, Arêas AP, Ho PL. Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756 [Abstract] [Full Text] [Related]
4. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation. Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U. Adv Exp Med Biol; 1995 Jun; 371B():799-802. PubMed ID: 7502900 [No Abstract] [Full Text] [Related]
5. Prevention of infections of the respiratory tract using the oral application of antigens. Tischner H. Z Erkr Atmungsorgane; 1991 Jun; 176(2-3):131-7. PubMed ID: 1858413 [No Abstract] [Full Text] [Related]
6. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections]. Luther P, Brachmann I, Werchan D, Wittig C, Tischner H. Z Erkr Atmungsorgane; 1990 Jun; 175(2):95-9. PubMed ID: 2264367 [Abstract] [Full Text] [Related]
8. Induction of immune responses in nasopharyngeal secretions after oral immunization with bacterial lysates. Berber A, Priego R, Igelsias L, Torres S, Camacho C. Adv Exp Med Biol; 1995 Oct; 371B():807-11. PubMed ID: 7502902 [No Abstract] [Full Text] [Related]
9. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study]. Cimadamore N, Agriesti G, Testa A, Borgarello R, Capo G, Crua G. Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472 [No Abstract] [Full Text] [Related]
10. Microbial epidemiology and carriage studies for the evaluation of vaccines. Coughtrie AL, Jefferies JM, Cleary DW, Doncaster CP, Faust SN, Kraaijeveld AR, Moore MV, Mullee MA, Roderick PJ, Webb JS, Yuen HM, Clarke SC. J Med Microbiol; 2019 Oct; 68(10):1408-1418. PubMed ID: 31418679 [Abstract] [Full Text] [Related]
13. Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections. Langereis JD, van der Flier M, de Jonge MI. Front Immunol; 2018 Oct; 9():1925. PubMed ID: 30190722 [Abstract] [Full Text] [Related]